Literature DB >> 10233655

Sarcoidosis in a patient with linear IgA disease.

W M Porter1, C M Hardman, J N Leonard, L Fry.   

Abstract

We report a patient with four conditions in association with linear IgA disease (LAD), only three of which have been reported previously; these latter are ulcerative colitis, autoimmune thyroid disease and carcinoma of the colon, although the carcinoma may have been caused by the ulcerative colitis in this case. Recently, our patient also presented with respiratory symptoms and was found to have sarcoidosis as well, a previously unreported association of this autoimmune bullous disorder. The aetiology of this development may be related to the patient's HLA status or possibly to his treatment with the immunosuppressive agent cyclophosphamide; it is also possible that it is coincidental.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233655     DOI: 10.1046/j.1365-2230.1999.00420.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  3 in total

Review 1.  Thyroid diseases and skin autoimmunity.

Authors:  Enke Baldini; Teresa Odorisio; Chiara Tuccilli; Severino Persechino; Salvatore Sorrenti; Antonio Catania; Daniele Pironi; Giovanni Carbotta; Laura Giacomelli; Stefano Arcieri; Massimo Vergine; Massimo Monti; Salvatore Ulisse
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

2.  Unusual clinicopathological and immunological presentation of chronic bullous dermatosis of childhood (linear IgA dermatosis).

Authors:  Al-Saif Fahad; Al-Rikabi Ammar
Journal:  Indian J Dermatol       Date:  2011 Sep-Oct       Impact factor: 1.494

3.  Linear IgA dermatosis associated with ulcerative colitis: complete and sustained remission after total colectomy.

Authors:  Thiago Jeunon de Sousa Vargas; Mônica Fialho; Luiza Tavares dos Santos; Palmira Assis de Jesus Barreto Rodrigues; Ana Luisa Bittencourt Sampaio Jeunon Vargas; Maria Auxiliadora Jeunon Sousa
Journal:  An Bras Dermatol       Date:  2013 Jul-Aug       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.